ID

16193

Description

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00080756

Lien

https://clinicaltrials.gov/show/NCT00080756

Mots-clés

Versions (1)
  1. 04/07/2016 04/07/2016 -
Téléchargé le

4 juillet 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility brca1 Mutation Carrier NCT00080756

Anglais

Eligibility brca1 Mutation Carrier NCT00080756

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must generally be in good health with lab values and physical examination within normal limits
Description

General health good | Laboratory Results Normal | Physical Examination Normal

Type de données

boolean

Alias
UMLS CUI [1]
C1277245
UMLS CUI [2,1]
C1254595
UMLS CUI [2,2]
C0205307
UMLS CUI [3,1]
C0031809
UMLS CUI [3,2]
C0205307
known high risk of breast cancer due to brca mutation or empiric risk > 30% lifetime by the claus model
Description

At high risk for breast cancer Due to brca gene Mutation | Lifetime Risk Empiric Claus Model

Type de données

boolean

Alias
UMLS CUI [1,1]
C4047809
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0596223
UMLS CUI [1,4]
C0026882
UMLS CUI [2,1]
C1517878
UMLS CUI [2,2]
C1880496
UMLS CUI [2,3]
C1707405
no evidence or history of pervious cancer, except non-melanoma skin cancer
Description

Malignant Neoplasms No evidence | Skin carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332125
UMLS CUI [2]
C0699893
premenopausal women planning risk reduction mastectomy in 6 months or more (group 1) or continued surveillance (group 2)
Description

Premenopausal Planning bilateral mastectomy for risk reduction | Premenopausal Continuous Surveillance

Type de données

boolean

Alias
UMLS CUI [1,1]
C0279752
UMLS CUI [1,2]
C1301732
UMLS CUI [1,3]
C3838456
UMLS CUI [2,1]
C0279752
UMLS CUI [2,2]
C1999123
prior tubal ligation or willing to use a non-hormonal barrier method of contraception
Description

Tubal Ligation | Female barrier contraception method Willing

Type de données

boolean

Alias
UMLS CUI [1]
C0520483
UMLS CUI [2,1]
C0558251
UMLS CUI [2,2]
C0600109
signed the informed consent form document for this study in accordance with all federal, state and institutional regulations
Description

Informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
must be current non-smoker
Description

Non-smoker

Type de données

boolean

Alias
UMLS CUI [1]
C0337672
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
gnrha treatment within 12 months of study entry
Description

gonadotropin releasing hormone agonists

Type de données

boolean

Alias
UMLS CUI [1]
C2012324
nasal polyposis, atrophic rhinitis, severe allergic or vasomotor rhinitis, or sinusitis requiring current treatment or treatment for more than 3 months in the previous year
Description

Nasal Polyps | Rhinitis, Atrophic | Allergic rhinitis Severe | Vasomotor Rhinitis Severe | Sinusitis Requirement Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0027430
UMLS CUI [2]
C0035459
UMLS CUI [3,1]
C2607914
UMLS CUI [3,2]
C0205082
UMLS CUI [4,1]
C0035460
UMLS CUI [4,2]
C0205082
UMLS CUI [5,1]
C0037199
UMLS CUI [5,2]
C1514873
UMLS CUI [5,3]
C0087111
concurrent medications including: corticosteroids (prednisone, prednisolone, cortisone acetate, decadron, deltasone, hydrocortisone, hydrocortone, medrol), estrogens, progestins or androgens, including oral, implanted, or injected contraceptive; (at least 6 months must have elapsed since the last use of an implanted or injected contraceptive such as norplant)
Description

Pharmaceutical Preparations | Adrenal Cortex Hormones | Prednisone | prednisolone | cortisone acetate | Decadron | Deltasone | Hydrocortisone | Hydrocortone | Medrol | Estrogens | Progestins | Androgens | Contraceptives, Oral | Contraceptive implant | Contraceptive injection | Norplant

Type de données

boolean

Alias
UMLS CUI [1]
C0013227
UMLS CUI [2]
C0001617
UMLS CUI [3]
C0032952
UMLS CUI [4]
C0032950
UMLS CUI [5]
C0056391
UMLS CUI [6]
C0740057
UMLS CUI [7]
C0740144
UMLS CUI [8]
C0020268
UMLS CUI [9]
C0699396
UMLS CUI [10]
C0699458
UMLS CUI [11]
C0014939
UMLS CUI [12]
C0033306
UMLS CUI [13]
C0002844
UMLS CUI [14]
C0009905
UMLS CUI [15]
C1657106
UMLS CUI [16]
C1656586
UMLS CUI [17]
C1145675
pregnant or breast-feeding or have been so in the last six months
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
immeasurable breast density on mammogram
Description

Mammography Breast Density Non-Measurable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024671
UMLS CUI [1,2]
C1659543
UMLS CUI [1,3]
C1518373
Retour au début de la page

Similar models

Eligibility brca1 Mutation Carrier NCT00080756

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
General health good | Laboratory Results Normal | Physical Examination Normal
Item
patients must generally be in good health with lab values and physical examination within normal limits
boolean
C1277245 (UMLS CUI [1])
C1254595 (UMLS CUI [2,1])
C0205307 (UMLS CUI [2,2])
C0031809 (UMLS CUI [3,1])
C0205307 (UMLS CUI [3,2])
At high risk for breast cancer Due to brca gene Mutation | Lifetime Risk Empiric Claus Model
Item
known high risk of breast cancer due to brca mutation or empiric risk > 30% lifetime by the claus model
boolean
C4047809 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0596223 (UMLS CUI [1,3])
C0026882 (UMLS CUI [1,4])
C1517878 (UMLS CUI [2,1])
C1880496 (UMLS CUI [2,2])
C1707405 (UMLS CUI [2,3])
Malignant Neoplasms No evidence | Skin carcinoma
Item
no evidence or history of pervious cancer, except non-melanoma skin cancer
boolean
C0006826 (UMLS CUI [1,1])
C0332125 (UMLS CUI [1,2])
C0699893 (UMLS CUI [2])
Premenopausal Planning bilateral mastectomy for risk reduction | Premenopausal Continuous Surveillance
Item
premenopausal women planning risk reduction mastectomy in 6 months or more (group 1) or continued surveillance (group 2)
boolean
C0279752 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C3838456 (UMLS CUI [1,3])
C0279752 (UMLS CUI [2,1])
C1999123 (UMLS CUI [2,2])
Tubal Ligation | Female barrier contraception method Willing
Item
prior tubal ligation or willing to use a non-hormonal barrier method of contraception
boolean
C0520483 (UMLS CUI [1])
C0558251 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
Informed consent
Item
signed the informed consent form document for this study in accordance with all federal, state and institutional regulations
boolean
C0021430 (UMLS CUI [1])
Non-smoker
Item
must be current non-smoker
boolean
C0337672 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
gonadotropin releasing hormone agonists
Item
gnrha treatment within 12 months of study entry
boolean
C2012324 (UMLS CUI [1])
Nasal Polyps | Rhinitis, Atrophic | Allergic rhinitis Severe | Vasomotor Rhinitis Severe | Sinusitis Requirement Therapeutic procedure
Item
nasal polyposis, atrophic rhinitis, severe allergic or vasomotor rhinitis, or sinusitis requiring current treatment or treatment for more than 3 months in the previous year
boolean
C0027430 (UMLS CUI [1])
C0035459 (UMLS CUI [2])
C2607914 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0035460 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0037199 (UMLS CUI [5,1])
C1514873 (UMLS CUI [5,2])
C0087111 (UMLS CUI [5,3])
Pharmaceutical Preparations | Adrenal Cortex Hormones | Prednisone | prednisolone | cortisone acetate | Decadron | Deltasone | Hydrocortisone | Hydrocortone | Medrol | Estrogens | Progestins | Androgens | Contraceptives, Oral | Contraceptive implant | Contraceptive injection | Norplant
Item
concurrent medications including: corticosteroids (prednisone, prednisolone, cortisone acetate, decadron, deltasone, hydrocortisone, hydrocortone, medrol), estrogens, progestins or androgens, including oral, implanted, or injected contraceptive; (at least 6 months must have elapsed since the last use of an implanted or injected contraceptive such as norplant)
boolean
C0013227 (UMLS CUI [1])
C0001617 (UMLS CUI [2])
C0032952 (UMLS CUI [3])
C0032950 (UMLS CUI [4])
C0056391 (UMLS CUI [5])
C0740057 (UMLS CUI [6])
C0740144 (UMLS CUI [7])
C0020268 (UMLS CUI [8])
C0699396 (UMLS CUI [9])
C0699458 (UMLS CUI [10])
C0014939 (UMLS CUI [11])
C0033306 (UMLS CUI [12])
C0002844 (UMLS CUI [13])
C0009905 (UMLS CUI [14])
C1657106 (UMLS CUI [15])
C1656586 (UMLS CUI [16])
C1145675 (UMLS CUI [17])
Pregnancy | Breast Feeding
Item
pregnant or breast-feeding or have been so in the last six months
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Mammography Breast Density Non-Measurable
Item
immeasurable breast density on mammogram
boolean
C0024671 (UMLS CUI [1,1])
C1659543 (UMLS CUI [1,2])
C1518373 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial